WHO ICTRP trial
Evaluation of oral zinc therapy in Acne Vulgaris disease
IRCT20190505043485N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20190505043485N1 |
|---|---|
| Public title | Evaluation of oral zinc therapy in Acne Vulgaris disease |
| Scientific title | Determination of the Effect of Oral zinc therapy on the Treatment of Acne vulgaris in Patients with Grade 2 and 3 Acne vulgaris |
| Primary sponsor | Boushehr University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Acne Vulgaris. Acne vulgaris;L70.0 |
| Interventions | Intervention 1: Intervention group: Patients in the intervention group in addition to the routine treatment of Acne Vulgaris (containing 1% topical Clindamycin gel and 1% topical Salicylic Acid gel) will receive Zinc Sulfate tablets 60 mg… |
| Registration date | Jun 1, 2019 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: